Press release dated September 23, 2026, titled "Glenmark Pharmaceuticals receives Establishment Inspection Report (EIR) from U.S. FDA for its Goa facility with VAI classification".
Ask the chart: “Has this stock recovered from similar drawdowns before?”
AI equity note (bull/bear, numbers, sources) — coming soon
Management guidance consistency — coming soon
Latest filings
NSE announcements · newest firstKey MetricsFull financials →
P/E (TTM)
37.4×
EPS ₹63.71
P / Book
6.39×
BVPS ₹373
ROE
14.1%
FY26, avg equity
Net margin
8.0%
FY26
Revenue YoY
+23.1%
Q1 FY27
Net profit YoY
+927.9%
Q1 FY27
Debt / equity
0.00×
₹0 Cr debt
Div. yield
0.21%
₹5.00 in 12 months
From NSE filings (consolidated) and the last close.
Shareholding Pattern Jun 2026
Promoter pledge: none reported
Peer Comparison
Peer comparison is unavailable right now.
Forensic Flags3 Watch
Receivables grew 49% against revenue growth of 27%
FY26: debtor days moved from 92 to 107.
Exceptional items above 5% of pre-tax profit in 5 of the last 5 years
FY22–FY26.
Results were filed late in 1 of the last 8 quarters
Slowest filing came 59 days after the period end.
Free cash flow was negative in 2 of the last 5 years
Operating cash flow less capital expenditure, as filed.
Other income is 23% of profit before tax
FY26.
Effective tax rate averaged 83%
Tax over pre-tax profit, last 3 years. The base corporate rate is about 25%.
8 checks within their thresholds
Operating cash flow was 1.74× net profit
Cumulative over FY22–FY26 (5 years).
Inventory grew 13% against revenue growth of 27%
FY26: inventory days moved from 83 to 74.
Debt to equity is 0.00×
As at 2026-03-31; it was 0.46× at 2023-03-31.
Profit before interest and tax covers finance costs 10.5×
FY26.
Share count changed +0.0% in three years, net of bonuses and splits
From 2023-03-31 to 2026-03-31. Shares issued for mergers, placements, conversions and stock options all count.
Promoter holding is 46.65%, +0.00 points over a year
2026-06-30 against 2025-06-30.
No promoter shares are pledged
Shareholding pattern as at 2026-06-30.
No auditor change or resignation filings in three years
From NSE announcements on record.
Computed from NSE filings (consolidated). Colours follow fixed thresholds, shown on hover. These are facts about the filings, not advice.
Formula Scores
Piotroski F-score: 9 of 9 · FY to 2026-03-31one point for each of nine tests on profitability, leverage and liquidity, and operating efficiency, comparing the year with the one before
- ✓ Return on assets positive: 8.49 — profit after tax over the year's opening total assets, %
- ✓ Operating cash flow positive: 3,445 — ₹ crore
- ✓ Cash flow above profit (accruals): 2,083.1 — operating cash flow less profit after tax, ₹ crore
- ✓ Return on assets improved: 1.19 — change in ROA, percentage points
- ✓ Long-term borrowings to assets fell: -3.19 — change in long-term borrowings over total assets, percentage points
- ✓ Current ratio improved: 0.21 — change in current assets over current liabilities
- ✓ No new shares issued: 0 — change in share capital, %
- ✓ Gross margin improved: 5.09 — revenue less material cost over revenue, change in percentage points
- ✓ Asset turnover improved: 0.13 — revenue over the year's opening total assets, change
Inputs: profit after tax ₹1,362 Cr (2026-03-31) · profit after tax ₹1,047 Cr (2025-03-31) · total assets ₹19,908 Cr (2026-03-31) · total assets ₹16,050 Cr (2025-03-31)
The paper's bands: 8–9: the paper's high group; 0–2: the paper's low group
Source: Joseph Piotroski, "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers", Journal of Accounting Research, 2000
Altman Z-score: 6.71 · FY to 2026-03-31Z = 1.2 × working capital / total assets + 1.4 × retained earnings / total assets + 3.3 × EBIT / total assets + 0.6 × market value of equity / total liabilities + 1.0 × sales / total assets
- working capital / total assets: 0.247 × 1.2
- retained earnings / total assets: 0.527 × 1.4 — reserves and surplus as retained earnings
- EBIT / total assets: 0.11 × 3.3 — profit before tax plus finance cost
- market value of equity / total liabilities: 7.425 × 0.6 — market capitalisation over total assets less equity
- sales / total assets: 0.853 × 1
Inputs: total assets ₹19,908 Cr (2026-03-31) · current assets ₹11,300 Cr (2026-03-31) · current liabilities ₹6,376 Cr (2026-03-31) · reserves ₹10,484 Cr (2026-03-31) · total equity ₹10,512 Cr (2026-03-31) · profit before tax ₹1,985 Cr (2026-03-31) · finance cost ₹209 Cr (2026-03-31) · revenue ₹16,983 Cr (2026-03-31) · market capitalisation (today) ₹69,769 Cr
The paper's bands: above 2.99: the paper's safe zone; 1.81–2.99: the grey zone; below 1.81: the distress zone
the 1968 form, fitted on manufacturers; reserves stand in for retained earnings, and profit before tax plus finance cost for EBIT
Source: Edward Altman, "Financial Ratios, Discriminant Analysis and the Prediction of Corporate Bankruptcy", Journal of Finance, 1968
Graham number: 635.86 ₹ per share · FY to 2026-03-31√(22.5 × earnings per share × book value per share): the price at which P/E × P/B = 22.5 (a P/E of 15 at a P/B of 1.5)
- earnings per share: 48.24
- book value per share: 372.51 — owners' equity over shares (paid-up capital / face value)
Inputs: earnings per share 48.24 (2026-03-31) · owners' equity ₹10,512 Cr (2026-03-31) · paid-up capital ₹28 Cr (2026-03-31) · face value 1 (2026-03-31)
a number the book uses as a ceiling for a defensive investor's purchase price; it is arithmetic on two reported figures, not a valuation
Source: Benjamin Graham, The Intelligent Investor (1949; the 22.5 in the 1973 edition's criteria for the defensive investor)
Sloan accrual ratio: -11.59 % of assets · FY to 2026-03-31(profit after tax − operating cash flow) / average total assets
Inputs: profit after tax ₹1,362 Cr (2026-03-31) · operating cash flow ₹3,445 Cr (2026-03-31) · total assets ₹19,908 Cr (2026-03-31) · total assets ₹16,050 Cr (2025-03-31)
how much of the year's profit was not cash; the paper sorts companies by this and reports the top decile's later returns
Source: Richard Sloan, "Do Stock Prices Fully Reflect Information in Accruals and Cash Flows about Future Earnings?", The Accounting Review, 1996
Each score is its published formula applied to the company's own filings (consolidated); open one for the tests, the inputs and the paper. Arithmetic on the filings, not a view on the stock.